Rybelsus Cost Without Insurance in 2026: Real Prices, the June Discontinuation, and the Replacement Starting at $149

Affiliate disclosure: Some links on The RX Index may be partner links, and we may earn a commission if you use one. It does not change what you pay, and it did not change what we found. The direct manufacturer path on this page pays us nothing, and we say so out loud below.

---

The bottom line

Rybelsus cost without insurance is $997.58 at list price. Current published cash prices we verified run from about $1,012 to $1,366 for 30 tablets. Headline discount-card prices run from about $903 to $1,014. The $25 manufacturer card will not help you if you are paying full cash—its own terms exclude full cash-paying patients.

Now here's the part almost nobody has told you yet.

On June 4, 2026, the FDA logged Rybelsus as discontinued. All three strengths. Novo Nordisk stopped manufacturing them. And the FDA's own record says these products “will be replaced by Ozempic (semaglutide) tablets.”

That same active ingredient—semaglutide—in a new FDA-approved tablet formula now has a published manufacturer self-pay price of $149 for the first 30-day starting dose. The standard self-pay prices after that are $199 at 4 mg and $299 at 9 mg.

So if you're staring at a four-figure quote for Rybelsus right now, you are being asked to pay nearly seven times more for a product that is on its way off the shelf. That's not a coupon problem. It's a which bottle problem, and we're going to walk you through it.

One thing before we go further: do not copy the milligram number from one bottle to the other. The products are not interchangeable milligram for milligram. The FDA label says Rybelsus 7 mg transitions to Ozempic tablet 4 mg, while Rybelsus 14 mg transitions to Ozempic tablet 9 mg. There is no Ozempic tablet 7 mg. Only your prescriber can make the switch.

---

Quick decision table

One month means one bottle of 30 tablets. Rybelsus prices come from Novo Nordisk, Drugs.com, GoodRx, and SingleCare. Ozempic tablet prices come from Novo Nordisk's current self-pay terms. All were checked August 14, 2026.

---

Is this page for you?

Yes, if:

• You have no insurance, or your plan won't cover Rybelsus
• A pharmacy quoted you $1,000 or more
• Your coupon got rejected at the counter
• Your pharmacy said Rybelsus is backordered or discontinued
• You want to know the real number before you call your doctor

No, and here's where to go instead:

• You have commercial insurance that covers Rybelsus. The $25 card may be for you if you meet all current terms. Read the official Rybelsus savings-offer terms before you go to the counter.
• You want to lose weight, not treat diabetes. Rybelsus was never FDA-approved for weight loss. Skip to that section—the answer is different and usually cheaper.
• You need dosing instructions. This is a price page. Your prescriber handles doses.

---

The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.

---

What we actually verified

On August 14, 2026, we opened and read:

• The FDA drug discontinuation database entry for semaglutide tablets, including all three Rybelsus product codes
• The current FDA-approved prescribing information for Rybelsus and Ozempic tablets
• Novo Nordisk's published Rybelsus list-price page
• The full Diabetes Savings Offer terms, including the pharmacist billing instructions most people never see
• The current Patient Assistance Program product list and an older official list still sitting on the same website
• Novo's current Ozempic and Wegovy tablet self-pay terms
• The NovoCare Pharmacy pages for patients and prescribers
• TrumpRx.gov product listings
• Current cash and coupon prices from GoodRx, SingleCare, and Drugs.com
• Current pricing and service pages from Ro and Sesame

What we did not verify: whether your specific pharmacy has Rybelsus on the shelf, what your final out-the-door price will be, whether you personally qualify for any program, or whether switching medicines is right for you. Those are yours and your prescriber's to answer.

---

Before you pick a path

The right GLP-1 provider isn't the same for everyone—it depends on your state, your insurance and drug list (formulary), whether you want an FDA-approved or compounded medication, your preferred treatment path, and your budget. Because a general answer can't resolve those for you, use The RX Index's Find My GLP-1 Path tool to get a personalized provider match with source-verified pricing before you choose.

---

How much does Rybelsus cost without insurance in 2026?

Rybelsus has one published list price: $997.58 for a 30-tablet package. That price is the same for 3 mg, 7 mg, and 14 mg—going up in dose does not raise the list price. The current published cash figures we verified run from $1,011.57 to $1,366.33. Headline discount prices run from $903.43 to $1,013.95, with one lower $658.20 rolling-data outlier that is not a guaranteed quote.

Four different numbers get thrown around, so let's define them once:

• List price—what the drugmaker publishes. For Rybelsus, $997.58.
• Retail or cash price—what a pharmacy charges before insurance or a discount card. It can be higher than list price.
• Discount price—what a free card like GoodRx or SingleCare shows.
• Your price—what you actually hand over after the pharmacy confirms stock and runs the card. This is the only number that matters.

Seven verified current prices in one place

We pulled seven current published Rybelsus price points and put them in one table:

GoodRx and SingleCare prices can change by dose, pharmacy, ZIP code, and day. SingleCare says its displayed prices are estimates and tells patients to confirm the exact price with the pharmacy.

Here's our math on the two headline SingleCare numbers: $1,366.33 minus $903.43 is a $462.90 gap on the same brand drug.

Read that again. The gap is more than three times the $149 first-month Ozempic tablet price. $149 × 3 is $447.

The rolling pharmacy data is even messier. SingleCare's current table puts its card average at $658.20 at CVS and $996 at Walmart—a $337.80 gap. That does not promise you either price. It proves that calling more than one pharmacy can matter.

What Rybelsus costs for a year

Medication only. This does not include doctor visits, lab work, or anything else. The table is simple arithmetic using the dated prices above; it does not promise that a pharmacy will keep the same price for 12 months.

Is there a generic Rybelsus?

No. There is no FDA-approved generic Rybelsus or FDA-approved generic oral semaglutide in the United States. An ad for “generic Rybelsus” is not describing an FDA-approved US generic. It may be a compounded product, an imported product, or something else. Check before you pay.

The honest catch, up front

A $1,011 coupon price is worthless if the pharmacy can't fill the prescription. Since manufacturing has stopped, a price listing in an app tells you what something would cost, not whether it exists on a shelf near you. Always confirm stock and price as two separate questions.

That's the whole reason the next section exists.

---

Was Rybelsus discontinued, and can pharmacies still fill it?

Yes, Rybelsus was discontinued from manufacture. The FDA database shows Novo Nordisk reported all three strengths—3 mg, 7 mg, and 14 mg—with a June 4, 2026 posting date. The FDA record says these products will be replaced by Ozempic tablets. A pharmacy may still fill a valid Rybelsus prescription if it has remaining stock, but the FDA record does not promise that stock exists near you.

Here is exactly what the federal record shows, product by product:

Source: FDA Drug Shortages and Discontinuations database, retrieved August 14, 2026.

A May 21 notice from Illinois Medicaid adds one useful supply detail: Novo Nordisk told that state agency that shipments to wholesalers would stop beginning in May 2026 and that existing inventory was expected to become limited starting in July. That notice applies to Illinois Medicaid, but the shipment timing helps explain why pharmacies may now give different answers.

Discontinued does not mean recalled

We want to be careful here, because this is where people get scared.

The FDA record says discontinuation of manufacture. It is not a recall notice. If you have Rybelsus in your cabinet right now, this database record does not say there is a safety problem with that bottle. Take it as prescribed and talk with your prescriber about what comes next.

So can your pharmacy still get it?

Maybe. Pills already in the supply chain don't vanish overnight. A pharmacy can fill Rybelsus only if it can get or already has your strength.

But “maybe” is a bad thing to build a $1,000 purchase on.

The exact question to ask your pharmacy

Most people call and ask “do you have Rybelsus?” and get a yes based on a computer screen, not a shelf. Ask this instead:

“Do you physically have Rybelsus [your strength] in the store right now, or is that only a wholesaler listing? What is my total cash price for 30 tablets after the discount card, and how long is that quote good for?”

Two questions, one call. That's how you avoid driving across town for a bottle that isn't there.

---

Can I use the $25 Rybelsus savings card without insurance?

No. Novo Nordisk's official terms say the Rybelsus offer excludes full cash-paying patients. The offer also requires commercial insurance that covers Rybelsus. If a pharmacist told you the card would not run, the rejection may be exactly what the current rules require.

That phrase—excludes full cash-paying patients—appears for both parts of the Rybelsus offer: once for 3 mg and again for 7 mg and 14 mg. It is not open to interpretation.

The part that proves it isn't just policy

We read all the way down to the pharmacist instructions, and we found something most price pages miss.

Novo gives pharmacists three separate ways to bill the Ozempic offer:

1. For commercially insured patients whose plan covers it
2. For commercially insured patients whose plan rejects it
3. For patients who are self-paying or choosing to pay outside insurance

For Rybelsus, Novo gives pharmacists one route: bill the patient's primary commercial insurance first, then submit the remaining balance as a secondary claim.

No primary covered claim means no balance for the Rybelsus offer to pay. There is no cash-pay billing path in Novo's Rybelsus instructions. The exclusion isn't only written into the policy—it's built into the plumbing.

That's why arguing at the counter usually goes nowhere. It isn't the pharmacist. It's the billing path.

What changed in January 2026

The Rybelsus card used to be better. Under Novo's older official terms, eligible patients could pay as little as $10, with maximum savings of $300 for a 30-day fill, $600 for 60 days, or $900 for 90 days. Effective January 2, 2026, the offer changed to as little as $25, with maximum savings of $100 for one month, $200 for two months, or $300 for three months. The 3 mg strength is limited to one month per redemption.

Old pages and screenshots can still show the $10 and $300 figures. If you built a plan around those old numbers, that's why the math did not work.

If you do have commercial insurance that covers Rybelsus, read the current official terms before using the card.

For everyone else, that door is closed.

### That door's closed. Three others aren't. The three live paths are: Ozempic tablets at the manufacturer self-pay price for type 2 diabetes; Ozempic injection through the Patient Assistance Program if you qualify; or the Wegovy pill for an FDA-approved weight-management use. → Take the free 60-second Find My GLP-1 Path quiz and get your personal action plan with current prices.

---

Can I get Rybelsus free through Novo's Patient Assistance Program?

No, not under the current 2026 product list. Novo Nordisk's Patient Assistance Program list, coded NNIPAP_11_01012026, includes one GLP-1 medicine: Ozempic injection, marked for uninsured patients only. Rybelsus is not on that list. Ozempic tablets and Wegovy are not on it either.

The Patient Assistance Program is Novo Nordisk's manufacturer assistance program. If you're approved, you can receive a listed medicine at no cost. There is no registration charge or monthly fee. It's real, and for the right person it's life-changing.

Here's what the current list says about GLP-1s:

For Ozempic injection, uninsured patients must have total household income at or below 200% of the federal poverty level. Medicare beneficiaries with prescription drug coverage are no longer eligible to receive Ozempic injection through this program. Other program rules still apply, including citizenship or legal-residency rules and limits tied to Medicaid, Extra Help, and other government programs.

Why so many websites still say Rybelsus is free

This is the strangest thing we found all week, and it explains a lot.

There are two official PAP product-list PDFs sitting on Novo Nordisk's website right now. They give opposite answers.

The current file is the one that controls this answer. The older file still loaded when we checked it on August 14, 2026.

If you found the old one—and a search engine can still serve an old PDF—you'd walk away certain that Rybelsus is available free.

A page can be honest and still be wrong if it reads the stale file.

We'd rather you hear it from a page that opened both.

If you're uninsured and low-income, the PAP may still be worth checking for Ozempic injection—not for Rybelsus or the Ozempic pill. Open the current product list before you spend an afternoon on paperwork.

---

The pill door that's open: starting at $149, no insurance needed

Novo Nordisk has a self-pay offer for Ozempic tablets. The published prices are $149 for the first 30-day 1.5 mg dose, $199 for 4 mg, and $299 for 9 mg—one bottle of 30 tablets each. You do not need insurance. You do not need prior authorization because the purchase runs outside insurance. You can use free home delivery or arrange local pharmacy pickup. The offer requires a valid prescription for an FDA-approved use and is valid only in the United States and its territories. Ozempic tablets are approved for adults with type 2 diabetes.

This is the answer. Everything before this section was clearing away the paths that don't work.

The prices, straight from Novo's terms

Prices come from NovoCare's current self-pay terms. The package codes come from FDA labeling, DailyMed, and Novo Nordisk's prescriber page. Novo's pricing table also lists 60- and 90-day totals for 1.5 mg, but the FDA label uses 1.5 mg only for days 1–30. Those longer totals are pricing math, not a dosing recommendation.

Manufacturer-stated vs verified: the 4 mg NDC mismatch

An NDC is the package code a pharmacy uses to identify the exact medicine, strength, and bottle size. We found one small but real error in NovoCare's own terms page:

NovoCare's price row says “30 tablets” but displays an NDC ending in -15. DailyMed and Novo's own prescriber page list the 30-tablet bottle as 0169-1704-30. That makes the terms-page NDC look like a page error. The price itself—$199 for one month—is the same on the live terms.

Something worth noticing: the 90-day price is exactly three times the monthly price. $149 × 3 = $447. $199 × 3 = $597. $299 × 3 = $897.

There is no bulk discount in NovoCare's standard tablet offer. A 90-day fill saves you two refill steps and two chances to run out—which is worth something—but not a dollar.

The full picture: what the replacement replaces

Putting the discontinued products next to the labeled transition makes the price gap impossible to miss:

This table explains the FDA-approved label. It does not tell you to switch, and it does not let you convert doses yourself.

What one year actually looks like

Our arithmetic uses Novo's published prices and the FDA-labeled starting schedule. It compares prices only. It does not predict which maintenance dose your prescriber will choose, and it does not claim the products work identically for every person. Visits and lab work are not included.

What the $149 gets you—and what it doesn't

Included:

• 30 tablets for the first month
• Free home delivery through NovoCare Pharmacy, or local pharmacy pickup if arranged
• No prior authorization because no insurance claim is used
• 90-day fills when the dose and prescription allow it
• Refill reminders by text or phone
• Prescription-transfer help; a pharmacy can call NovoCare Pharmacy at 1-833-949-5527

Not included, and this matters:

• A prescription. You still need a licensed prescriber.
• A doctor's visit. If you don't have a doctor, that cost is separate.
• Any insurance credit. The purchase runs outside insurance and cannot be counted toward your deductible or out-of-pocket limit.
• Stacking with another savings offer. The self-pay price cannot be combined with another copay or savings card.

NovoCare says it accepts credit cards, Apple Pay, Google Pay, health savings account (HSA) cards, and flexible spending account (FSA) cards. Using an HSA or FSA does not turn the purchase into an insurance claim. Confirm acceptance at checkout because payment rules can change.

What real customers say about the ordering process

Novo Nordisk publishes patient feedback on its NovoCare Pharmacy page. One customer says:

“I find the process of ordering very simple and straightforward.”

Other manufacturer-hosted comments describe on-time delivery, easy refills, and a smooth setup. These are testimonials selected and hosted by Novo Nordisk. They describe the ordering service only—not how well the medicine works, safety, or typical medical results.

Is TrumpRx a better deal?

No price advantage showed up in our check. TrumpRx lists the Ozempic pill starting at $149 under Novo Nordisk's self-pay terms. It is another way to access the same starting price, not a hidden lower tier.

Use whichever front door you like. Don't spend an afternoon hunting for a difference that isn't there.

One nuance if you're on Medicare

You'll see “government beneficiaries excluded” on copay cards, and that's true for the commercial-insurance savings card. The self-pay offer is different. Novo's terms allow a person with Medicare or another government plan to buy the medicine outside the plan, but the purchase cannot be submitted for reimbursement or counted toward the plan's deductible or out-of-pocket total.

### If you already have a prescriber, you're done. Go get it. Seriously—you don't need us, a telehealth company, or anyone else. Ask your prescriber to send the prescription to NovoCare Pharmacy and use the published self-pay offer if you qualify. That's the cheapest direct path on this page, and it pays us nothing. The real bottleneck is different for most people: you don't have a prescriber, or yours cannot see you soon. If that's you and you're treating type 2 diabetes: Sesame offers online diabetes visits with no membership fee and no insurance required. Before you pay, confirm that the clinician can prescribe the new Ozempic tablets for your case and send the prescription to NovoCare Pharmacy. A visit does not guarantee a prescription. (Partner link.)

---

How do I switch from Rybelsus to Ozempic tablets?

You need your prescriber to issue a prescription for the correct Ozempic tablet product and strength. The tablets do not match one-to-one by milligram. The FDA label says not to switch during the first 30 days. After that initiation phase, the labeled transitions are Rybelsus 7 mg to Ozempic tablet 4 mg and Rybelsus 14 mg to Ozempic tablet 9 mg.

The dose pairings

Why aren't the numbers the same? The newer formula has higher oral bioavailability. The FDA label estimates about 0.4%–1% for Rybelsus and 1%–2% for Ozempic tablets, and it reports comparable average exposure across the paired strengths. In plain English: the new tablet gets more semaglutide into the body, so the milligram number can be lower.

Do not do this conversion yourself. There is no 7 mg Ozempic tablet. Lining these up in a table is not permission to swap—it's context for the conversation you're about to have.

Yes, you need the correct new prescription

The product name, strength, and NDC change. Novo's prescriber page gives separate prescribing details for the 1.5 mg, 4 mg, and 9 mg tablets. A pharmacy cannot fill an old Rybelsus prescription as Ozempic tablets.

Any page telling you to keep the same 3 mg, 7 mg, or 14 mg numbers for the Ozempic pill is wrong. Someone who believes it can show up at the pharmacy with a prescription that cannot be filled and lose a week.

What to say to your doctor

Copy this. Send it in a portal message, read it over the phone, whatever's easiest:

“I've been taking Rybelsus [your dose] for type 2 diabetes. I'm paying cash and it's running about $1,000 a month. The FDA lists all three Rybelsus strengths as manufacturing discontinuations posted June 4, 2026, and Novo Nordisk has an Ozempic tablet self-pay offer for $149 to $299. Can we talk about whether the labeled Ozempic tablet transition is right for me? If it is, can you send the new prescription to NovoCare Pharmacy?”

That's it. You're not asking them to do anything unusual. You're asking about a manufacturer-published transition.

The morning routine doesn't change

Same rules as Rybelsus, and they're strict:

• First thing in the morning, on an empty stomach
• Swallow the tablet whole with no more than 4 ounces of plain water—not coffee, not juice
• Wait at least 30 minutes before eating, drinking anything else, or taking other pills

If that routine was already hard for you, switching to a smaller tablet doesn't make it easier. That's worth raising with your prescriber, because it's a real reason some people prefer a weekly injection.

---

What if I was taking Rybelsus for weight loss, not diabetes?

Rybelsus is FDA-approved for adults with type 2 diabetes, not for weight loss. Its label also includes lowering the risk of major heart events in certain adults with type 2 diabetes. If a doctor prescribed it off-label for weight loss, an insurer may deny it because that use is outside the label. Coverage still depends on the plan. There is now an FDA-approved oral semaglutide product for chronic weight management in eligible adults: the Wegovy pill. Its manufacturer self-pay price also starts at $149.

If you just recognized yourself, take a breath. This is one reason someone lands on this page paying $1,000 a month.

You were prescribed a diabetes-labeled pill for a weight goal. Your insurer may have said no because the use was off-label. So you've been carrying the full cost of a product that does not match the FDA-approved weight-management label.

There's a better-fitting product now, and it can be cheaper.

The Wegovy pill self-pay ladder

The 4 mg limited-time offer has exact gates: the patient must be new to Wegovy tablets through NovoCare Pharmacy, the prescription must be written and received by August 31, 2026, and the bottle must ship by September 30, 2026. The offer is for one 30-tablet fill.

A real deadline, with a strange twist

We found something odd, and it can be worth $50.

Novo's dedicated Wegovy savings page and current terms show the eligible 4 mg fill at $149 through August 31, 2026, then the standard price is $199. Ro also shows the same dated 4 mg offer.

But NovoCare's broad pharmacy landing page still summarizes the 4 mg Wegovy pill at $199. The detailed, dated terms explain who gets $149 and when. Same company. Same product. Two pages that can lead a normal person to two different numbers.

The clean answer is simple: check the dated eligibility rules and the price shown before you pay. Do not assume every 4 mg fill is $149.

Straight talk about going through a telehealth company

Ro does not sell you the Wegovy pill at $149 and stop there. There is a separate Ro Body membership on top: $39 for the first month, then $149 month to month, or as low as $74 a month if you prepay for a year. Medication is separate. Your honest first-month total at the $149 starting dose is $188, before any other cost.

If the lowest possible price is your only priority and you already have a doctor, skip Ro entirely and have that doctor send a Wegovy pill prescription to NovoCare Pharmacy. Same FDA-approved brand product, no Ro membership.

But here's what that fee actually buys, and for a lot of people it's the difference between starting and not starting: access to licensed providers, a treatment plan, dose adjustments, side-effect support, regular check-ins, and insurance help. The medication cost is not included in the membership. This Wegovy-pill path uses the FDA-approved brand product.

If you don't have a doctor right now, and the alternative is spending weeks finding one while you keep paying $1,000 for Rybelsus, the membership isn't the expensive part of that equation.

Does that sound like your situation? → Check current Wegovy pill and membership pricing on Ro. (Partner link.) Not sure whether your goal is blood sugar or weight? That changes the answer and the price. Find My GLP-1 Path sorts it out in about a minute.

---

What do I do if my pharmacy can't fill Rybelsus at all?

Don't wait until your last tablet. Confirm whether the pharmacy physically has your strength, get a complete out-the-door price, then contact your prescriber about the FDA-labeled replacement or another diabetes treatment.

Five steps, in order:

1. Confirm real stock. Ask whether the medicine is physically in the store or only showing in the computer. These are different answers.

2. Get the complete price. Exact strength, 30 tablets, cash price, discount-card price, and how long the quote is good for. Write it down.

3. Call two more pharmacies. Include one independent pharmacy. Stock and wholesaler access can differ, and current published card prices differ by hundreds of dollars.

4. Message your prescriber. Use the script above. Tell them how many tablets you have left.

5. Ask where the new prescription should go. Local pickup or NovoCare Pharmacy delivery can both work. NovoCare says delivery is free.

Free: the pharmacy price-check sheet

We built the worksheet into the page so there is no dead download link and no email gate. Print this section or copy it into your notes:

Three calls with this sheet in front of you can be done in one sitting. Current published prices show why the calls matter.

---

What else should I budget for besides the pills?

The $149 to $299 self-pay price covers medication only. If you don't already have a prescriber, add the cost of a visit. Your clinician may also order lab work or follow-up visits based on your diabetes history. NovoCare Pharmacy delivery is free.

That HSA/FSA point is worth ten seconds of attention. If you have eligible pretax money sitting there, using it may lower your after-tax cost. The exact savings are personal, so we are not going to turn it into a fake universal percentage.

---

Who should not take Rybelsus or Ozempic tablets?

According to the FDA-approved label, these tablets should not be used by people with a personal or family history of medullary thyroid carcinoma, people with Multiple Endocrine Neoplasia syndrome type 2, or anyone who has had a serious allergic reaction to semaglutide or an ingredient in the product. This is a summary, not the full label, and it is not a substitute for talking to your prescriber.

Do not use if you have:

• A personal or family history of medullary thyroid carcinoma (MTC)
• Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)—an inherited condition affecting hormone glands
• A history of a serious allergic reaction to semaglutide or any ingredient

Tell your prescriber before starting if you have or have had:

• Pancreas problems or kidney problems
• Eye problems related to diabetes
• Severe stomach-emptying problems, including gastroparesis
• Any surgery or procedure with anesthesia or deep sedation coming up
• Plans to become pregnant; the label says to stop semaglutide at least two months before a planned pregnancy
• Breastfeeding plans; breastfeeding is not recommended while taking Ozempic tablets
• Any use of insulin or a sulfonylurea, because the combination can raise low-blood-sugar risk

The label also warns about pancreatitis, vision changes, low blood sugar, dehydration that can lead to kidney problems, severe stomach problems, gallbladder problems, serious allergic reactions, and food or liquid getting into the lungs during anesthesia.

Call your prescriber right away for severe stomach pain that will not go away or for nausea, vomiting, or diarrhea that will not stop. Stop the medicine and get medical help right away for signs of a serious allergic reaction, such as swelling of the face or throat, trouble breathing or swallowing, fainting, or a severe rash.

None of that is a reason to panic. It's a reason to have one honest conversation before you start.

---

Is it safe to buy Rybelsus from an online pharmacy or a compounding pharmacy?

Be careful. A price far below the normal US market is a warning sign, not proof of fraud. FDA guidance says unsafe online sellers may skip prescription rules, hide where the medicine comes from, or ship products outside normal US safeguards. Compounded semaglutide is a separate category: compounded drugs are not FDA-approved, and they are not FDA-approved generic versions of Rybelsus or Ozempic.

We're not accusing anyone of anything. We're telling you what to check.

Before you buy from any online pharmacy, verify:

• It requires a valid prescription
• It has a US physical address and phone number
• A licensed pharmacist is available to answer questions
• It is licensed by a state board of pharmacy, and you can confirm that license with the board itself

The FDA's BeSafeRx guidance tells buyers to check those points before ordering.

On compounded semaglutide

Compounded drugs may be prepared by state-licensed pharmacies, physicians, or FDA-registered outsourcing facilities under specific legal conditions. They are not FDA-approved finished products. The FDA does not review each compounded product for safety, effectiveness, or quality before it is sold the way it reviews an approved drug.

Compounding can serve a real patient need in limited situations allowed by federal and state law. That does not make the compounded product FDA-approved or a generic. Marketers cannot honestly call it “generic Ozempic,” “generic Rybelsus,” or the same FDA-approved product.

On March 3, 2026, the FDA announced 30 warning letters over marketing that presented unapproved GLP-1 products as the same as, or generic versions of, approved drugs. The agency has also warned about fraudulent compounded GLP-1 products with false labels and pharmacy information.

We deliberately left compounded options out of every price comparison on this page. Rybelsus and Ozempic tablets are FDA-approved finished products. Comparing them with compounded products on price alone would compare two different regulatory categories—and this page is about a diabetes medicine, where that distinction matters more, not less.

---

Will Rybelsus get cheaper in 2027?

Its published list price is scheduled to fall, but that is not a reliable cash-pay plan. Novo Nordisk announced that the wholesale list price for Rybelsus 7 mg and 14 mg will fall to $675 on January 1, 2027. The same announcement says the change will not affect direct-to-patient self-pay prices. Rybelsus manufacturing has already been discontinued, so a lower future list price does not guarantee future stock.

Read that carefully, because it's the difference between list price and the price you can actually use.

The $675 figure can matter to someone whose out-of-pocket cost is tied to list price, such as a person with coinsurance or a high deductible. It does not replace the current $149–$299 Ozempic tablet self-pay offer.

The 2027 announcement names Ozempic injection, not Ozempic tablets, in its product-specific list. So this page does not claim that the Ozempic pill's list price will become $675.

If you are paying cash for Rybelsus now, waiting for 2027 is not a clean savings strategy. Talk with your prescriber about a current option before paying another four-figure bill.

---

How we built this page

We're The RX Index—independent guidance for choosing your GLP-1 path. We don't sell medication, and we don't take money from Novo Nordisk.

How this page was made: On August 14, 2026, we opened the FDA's drug discontinuation database and pulled the semaglutide tablet record product code by product code. We read the current FDA label, Novo Nordisk's Rybelsus list-price page, the complete Diabetes Savings Offer terms, both official Patient Assistance Program product lists, the Ozempic and Wegovy self-pay terms, and the NovoCare Pharmacy pages for patients and prescribers. We checked TrumpRx, Ro, Sesame, GoodRx, SingleCare, and Drugs.com. Every price on this page traces to a named source and a date.

What this page adds: seven current Rybelsus price points in one table; a cash-card billing comparison; the two conflicting official PAP files; the corrected first-30-day switch rule; a manufacturer-stated-versus-verified NDC check; exact one-year cost math; and a printable pharmacy call sheet.

Why this page exists: because live pages can still show old savings-card terms, a stale PAP file can still say Rybelsus is free, and a price app cannot tell you whether a discontinued product is physically on a shelf. Those live pages can send readers toward paths that no longer work while a $149 starting option sits in plain sight.

What we didn't do: we didn't call every pharmacy in America, we didn't verify your eligibility for anything, and we can't tell you whether switching medicines is medically right for you. Prices and program rules change—that's why the verification date is at the top, and why we recheck this page monthly.

Read our research methodology, corrections policy, and about page for more on how The RX Index works.

---

Frequently asked questions

How much is a 30-day supply of Rybelsus without insurance? The published list price is $997.58 for 30 tablets, the same for 3 mg, 7 mg, and 14 mg. Current published cash figures we verified run from about $1,012 to $1,366. Headline discount-card figures run from about $903 to $1,014, with one lower rolling-data outlier that is not a guaranteed quote.

Is Rybelsus discontinued? Yes. The FDA database shows all three strengths as manufacturing discontinuations posted June 4, 2026. A pharmacy may fill remaining stock, but the FDA record does not promise local availability.

Was Rybelsus recalled? No recall is shown in the FDA record we checked. The record says manufacturing was discontinued.

What replaced Rybelsus? Ozempic semaglutide tablets, per the FDA record. They have the same active ingredient in a new formula and different strengths: 1.5 mg, 4 mg, and 9 mg.

Is the Ozempic pill cheaper than Rybelsus without insurance? Yes, under the current manufacturer self-pay offer. Ozempic tablets are $149, $199, or $299 a month depending on strength, versus a $997.58 Rybelsus list price and current cash figures around $1,012–$1,366.

Can I use the $25 Rybelsus savings card without insurance? No. Novo Nordisk's terms exclude full cash-paying patients and require commercial insurance coverage for Rybelsus.

Can I get Rybelsus free through the Patient Assistance Program? Not under the current 2026 product list. The current list does not include Rybelsus or Ozempic tablets. It includes Ozempic injection for uninsured patients who meet the program's rules.

Does GoodRx or SingleCare work for Rybelsus without insurance? A pharmacy discount card can be used outside insurance. The final price depends on dose, pharmacy, ZIP code, and stock. A coupon price does not guarantee the pharmacy has Rybelsus.

Is there a generic Rybelsus? No. There is no FDA-approved generic Rybelsus or FDA-approved generic oral semaglutide in the United States.

Do I need a new prescription for Ozempic tablets? Yes. The product name, strength, and NDC are different. A pharmacy cannot turn an old Rybelsus prescription into an Ozempic tablet prescription.

Can I switch from Rybelsus 7 mg to Ozempic tablet 7 mg? No—there is no 7 mg Ozempic tablet. The FDA-labeled transition is Rybelsus 7 mg to Ozempic tablet 4 mg after the initiation phase, if your prescriber makes that switch.

Can I switch from Rybelsus 3 mg to Ozempic tablet 1.5 mg? Do not switch during the first 30-day initiation phase. After day 30, your prescriber decides the maintenance plan.

Is a 90-day Ozempic tablet supply cheaper? No. Novo's standard 90-day self-pay prices are exactly three times the monthly prices: $447, $597, and $897. You save refill steps, not money.

Can I use my HSA or FSA? NovoCare says HSA and FSA payment cards are accepted. Confirm at checkout because program and payment rules can change.

Is delivery free? Yes. NovoCare Pharmacy says home shipping and delivery are free. Local pharmacy pickup can also be arranged.

I'm on Medicare. Can I use the $149 price? The commercial copay card excludes government beneficiaries. Novo's self-pay terms allow government-insured patients to pay outside their plan, but the purchase cannot be reimbursed or counted toward the plan's deductible or out-of-pocket total.

Was Rybelsus approved for weight loss? No. Rybelsus is approved for adults with type 2 diabetes, not weight loss. The Wegovy pill is the oral semaglutide product approved for weight management, and its current manufacturer self-pay price starts at $149.

---

Still not sure which GLP-1 program is right for you? Take our free 60-second matching quiz.

→ Get My Personalized Action Plan

The RX Index's Find My GLP-1 Path tool matches your state, your coverage, your medication preference, and your budget to a treatment path with source-verified pricing. No cost, no signup wall.

---

Related resources

• Find My GLP-1 Path
• How The RX Index researches and scores treatment paths
• The RX Index corrections policy
• About The RX Index

Sources

All sources below were retrieved or rechecked August 14, 2026 unless another date is stated.

1. FDA Drug Shortages and Discontinuations database—semaglutide tablets.
2. FDA-approved prescribing information for Rybelsus and Ozempic tablets.
3. FDA-approved prescribing information for Wegovy tablets and injection.
4. DailyMed—Ozempic and Rybelsus tablet labeling and package NDCs.
5. Illinois HFS provider notice—Rybelsus Tablets Transition to Ozempic Tablets.
6. Novo Nordisk—Rybelsus list price.
7. Novo Nordisk—current Diabetes Savings Offer terms and pharmacist instructions.
8. Novo Nordisk—older official Rybelsus savings terms.
9. Novo Nordisk—Patient Assistance Program rules.
10. Novo Nordisk—current PAP product list, NNIPAP_11_01012026.
11. Novo Nordisk—older PAP product list, © 2019, still live when checked.
12. Novo Nordisk—NovoCare Pharmacy self-pay terms.
13. Novo Nordisk—Ozempic tablet prescribing details and NDCs.
14. Novo Nordisk—NovoCare Pharmacy Ozempic page.
15. Novo Nordisk—Wegovy savings page.
16. TrumpRx—Ozempic Pill.
17. Novo Nordisk—February 24, 2026 list-price announcement.
18. GoodRx—Rybelsus price information.
19. SingleCare—Rybelsus prices and rolling pharmacy data.
20. Drugs.com—Rybelsus prices.
21. Ro—current weight-loss program and Wegovy pill pricing.
22. Sesame—online diabetes visits.
23. FDA—BeSafeRx online-pharmacy guidance.
24. FDA—Compounding and FDA: Questions and Answers.
25. FDA—February 6, 2026 action statement on non-FDA-approved GLP-1 drugs.
26. FDA—March 3, 2026 warning letters to 30 telehealth companies.
27. FDA—concerns with unapproved GLP-1 drugs.

---

This page is about prices and availability. It is not medical advice, and it is not a dosing guide. Rybelsus and Ozempic tablets are prescription medicines for adults with type 2 diabetes. Wegovy tablets are prescription medicines for eligible adults using them for an FDA-approved weight-management or cardiovascular-risk-reduction use. Only a licensed clinician can decide whether one is right for you or what dose to take. Do not start, stop, or switch a medicine based on this page. Prices, program terms, and product availability change—check the verification date at the top and confirm current pricing before you buy.